| Market Cap | 513M 456M 426M 388M 731M 49.41B 741M 5.16B 2B 25.16B 1.93B 1.89B 80.83B | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 460M 409M 382M 348M 656M 44.3B 665M 4.62B 1.79B 22.56B 1.73B 1.69B 72.47B | EV / Sales 2017 |
53,919,197x | EV / Sales 2018 | 19,487,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 352M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,025B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 623B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 459B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 355B | |
| -0.39% | -3.47% | +22.34% | +40.21% | 336B | |
| -0.17% | -1.55% | +13.38% | +26.31% | 270B | |
| -0.35% | -4.54% | -3.79% | +9.42% | 247B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 220B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 183B | |
| Average | -0.72% | -1.89% | +27.26% | +57.61% | 413.14B | |
| Weighted average by Cap. | -0.64% | -2.11% | +30.35% | +69.48% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.73 2.56 2.33 4.39 296.35 4.45 30.93 11.97 150.93 11.56 11.31 484.76 | 18.69 16.6 15.53 14.15 26.64 1.8K 27 187.84 72.71 916.6 70.18 68.66 2.94K |
| Net income | -8.89M -7.9M -7.39M -6.73M -12.67M -856M -12.84M -89.35M -34.59M -436M -33.38M -32.66M -1.4B | -8.41M -7.47M -6.99M -6.37M -11.99M -810M -12.15M -84.55M -32.73M -413M -31.59M -30.91M -1.33B |
| Net Debt | -1.84M -1.63M -1.53M -1.39M -2.62M -177M -2.66M -18.48M -7.15M -90.17M -6.9M -6.75M -290M | -53.08M -47.14M -44.09M -40.17M -75.63M -5.11B -76.67M -533M -206M -2.6B -199M -195M -8.36B |
Employees
-
Sector
Pharmaceuticals
